ICU · trading date Oct 13, 2026 · previous close $3.84 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$1.23M
Net income
-$12.15M
Total assets
$14.16M
Total liabilities
$3.74M
Stockholders' equity
$10.42M
Cash & equivalents
—
Operating income
-$12.18M
Operating cash flow
-$13.60M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-25.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-986.6%
Net margin
-984.6%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
26.4%
Equity / assets
73.6%
CapEx / revenue
—
Operating cash flow / net income
1.12×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Denver, CO 80216
3513 BRIGHTON BLVD
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.